Display options
Share it on

Prz Menopauzalny. 2014 Jun;13(3):180-5. doi: 10.5114/pm.2014.43822. Epub 2014 Jun 30.

Classical radical hysterectomy and nerve-sparing radical hysterectomy in the treatment of cervical cancer.

Przeglad menopauzalny = Menopause review

Marcin Makowski, Marek Nowak, Marian Szpakowski, Jacek Władziński, Anna Serwach-Nowińska, Łukasz Janas, Jacek R Wilczyński

Affiliations

  1. Department of Gynecology and Gynecologic Oncology, Polish Mother's Memorial Hospital - Research Institute in ?ód?, ?ód?, Poland.

PMID: 26327852 PMCID: PMC4520361 DOI: 10.5114/pm.2014.43822

Abstract

AIM OF THE STUDY: To compare Piver III radical hysterectomy (RH) with nerve-sparing radical hysterectomy (NSRH) for cervical cancer patients in terms of postoperative physiology of pelvic autonomic nerves and perioperative complications.

MATERIAL AND METHODS: Seventy-three consecutive patients with invasive cervical cancer underwent RH (53 cases) or NSRH (20 cases) from 2001 to 2012 at the Department of Gynecology and Gynecologic Oncology of Polish Mother's Memorial Hospital - Research Institute in Łódź.

RESULTS: Compared with patients treated with RH, patients who underwent NSRH presented no significant difference in terms of operative time (146 vs. 143 minutes, p > 0.05), blood loss and hospital stay (9.2 vs. 7.5 days, p > 0.05). A positive surgical margin was found in 6 cases of RH. No serious surgical complications were found in the NSRH group, while there were 4 cases in the RH group.

CONCLUSIONS: Nerve-sparing radical hysterectomy is safe and feasible surgical management for cervical cancer patients, which should improve the physiology of the pelvic autonomic nerve system postoperatively. The technique is relatively new and its oncologic efficiency has not been fully established yet, moreover it requires sophisticated anatomical knowledge and high operative skills.

Keywords: cervical cancer; classical radical hysterectomy; nerve-sparing radical hysterectomy; perioperative outcome; surgical treatment

References

  1. Obstet Gynecol. 1974 Aug;44(2):265-72 - PubMed
  2. Int J Gynecol Cancer. 2010 Oct;20(7):1274-83 - PubMed
  3. Crit Rev Oncol Hematol. 2003 Dec;48(3):271-9 - PubMed
  4. Zhonghua Fu Chan Ke Za Zhi. 2009 Aug;44(8):605-9 - PubMed
  5. Int J Gynecol Cancer. 2005 Mar-Apr;15(2):389-97 - PubMed
  6. Gynecol Oncol. 2007 Jan;104(1):186-91 - PubMed
  7. Int J Gynecol Cancer. 2006 May-Jun;16(3):1119-29 - PubMed
  8. Lancet Oncol. 2008 Mar;9(3):297-303 - PubMed
  9. Acta Obstet Gynecol Scand. 2005 Sep;84(9):868-74 - PubMed
  10. Zentralbl Gynakol. 2006 Feb;128(1):23-6 - PubMed
  11. Ginekol Pol. 2008 Feb;79(2):92-8 - PubMed
  12. J Obstet Gynaecol Res. 2000 Feb;26(1):1-8 - PubMed
  13. Baillieres Clin Obstet Gynaecol. 1988 Dec;2(4):953-62 - PubMed
  14. BJOG. 2004 May;111(5):456-62 - PubMed
  15. Am J Obstet Gynecol. 1998 May;178(5):971-6 - PubMed
  16. Obstet Gynecol. 1982 Jan;59(1):101-4 - PubMed
  17. Tohoku J Exp Med. 2007 Aug;212(4):403-13 - PubMed
  18. Anat Sci Int. 2002 Sep;77(3):161-8 - PubMed
  19. Tumori. 2003 Sep-Oct;89(5):497-501 - PubMed
  20. Gynecol Oncol. 2000 Apr;77(1):155-63 - PubMed

Publication Types